Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Promise Bio

Promise Bio utilizes AI to analyze epiproteomics for autoimmune diseases.
2023
11-50
Tel Aviv, Tel Aviv, Israel
Artificial IntelligenceBiotechnologynologyHealth CarePrecision Medicine

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

8.3M

Last Funding Date

16-12-2024

Startup Stage

Seed

Lead Investors

AstraZeneca, Pfizer, Israel Innovation Authority, Awz Ventures

People

Founders